HBK Investments L P bought a new stake in Fortrea Holdings Inc. (NASDAQ:FTRE – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 191,992 shares of the company’s stock, valued at approximately $1,450,000. HBK Investments L P owned 0.21% of Fortrea as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Fortrea in the fourth quarter valued at $30,000. GF Fund Management CO. LTD. purchased a new position in Fortrea during the 4th quarter valued at about $35,000. Janus Henderson Group PLC grew its position in Fortrea by 4.9% in the 4th quarter. Janus Henderson Group PLC now owns 43,298 shares of the company’s stock valued at $809,000 after acquiring an additional 2,006 shares in the last quarter. Quarry LP increased its stake in Fortrea by 73.4% during the first quarter. Quarry LP now owns 7,567 shares of the company’s stock worth $57,000 after purchasing an additional 3,202 shares during the period. Finally, Brooklyn Investment Group increased its stake in Fortrea by 9,577.5% during the first quarter. Brooklyn Investment Group now owns 3,871 shares of the company’s stock worth $29,000 after purchasing an additional 3,831 shares during the period.
Fortrea Stock Up 2.1%
FTRE opened at $9.85 on Monday. Fortrea Holdings Inc. has a 52 week low of $3.97 and a 52 week high of $25.28. The business has a 50 day moving average price of $6.36 and a two-hundred day moving average price of $7.07. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 1.87. The company has a market cap of $894.38 million, a PE ratio of -0.87 and a beta of 1.88.
Wall Street Analyst Weigh In
Several research analysts have recently commented on FTRE shares. Robert W. Baird raised shares of Fortrea from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $7.00 to $9.00 in a research note on Monday, August 4th. Baird R W raised shares of Fortrea from a “hold” rating to a “strong-buy” rating in a research report on Monday, August 4th. Cowen restated a “hold” rating on shares of Fortrea in a research note on Wednesday, May 14th. Mizuho reduced their price objective on Fortrea from $8.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, July 11th. Finally, Evercore ISI raised their target price on shares of Fortrea from $5.00 to $7.00 and gave the stock an “in-line” rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.22.
Read Our Latest Report on Fortrea
Insider Buying and Selling at Fortrea
In other Fortrea news, CFO Jill G. Mcconnell sold 4,886 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $8.01, for a total transaction of $39,136.86. Following the completion of the transaction, the chief financial officer owned 54,770 shares in the company, valued at approximately $438,707.70. This represents a 8.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Peter M. Neupert bought 32,500 shares of the stock in a transaction dated Monday, August 11th. The stock was purchased at an average cost of $6.26 per share, for a total transaction of $203,450.00. Following the acquisition, the director owned 98,132 shares of the company’s stock, valued at approximately $614,306.32. This represents a 49.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 10,207 shares of company stock worth $61,325 over the last three months. 0.38% of the stock is currently owned by corporate insiders.
About Fortrea
Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.
Featured Stories
- Five stocks we like better than Fortrea
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Top 5 September Stock Picks: Market Tailwinds Drive New Momentum
- How to Calculate Return on Investment (ROI)
- ACM Research: Why This Chinese Chip Stock Is Just Getting Started
- What Do S&P 500 Stocks Tell Investors About the Market?
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
Want to see what other hedge funds are holding FTRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fortrea Holdings Inc. (NASDAQ:FTRE – Free Report).
Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter.